Dashboard
Manage Tickers

NNVCNANOVIRICIDES, INC.

NYSE nanoviricides.com


$ 1.93 $ -0.68 (-26.36 %)    

Friday, 14-Jun-2024 13:03:04 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 1.9
$ 2.28
$ 0.00 x 0
$ 0.00 x 0
$ 1.93 - $ 2.28
$ 1.00 - $ 3.59
691,104
na
22.38M
$ 0.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-Q
3 11-14-2023 09-30-2023 10-Q
4 10-13-2023 06-30-2023 10-K
5 05-15-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 10-13-2022 06-30-2022 10-K
9 05-16-2022 03-31-2022 10-Q
10 02-14-2022 12-31-2021 10-Q
11 11-15-2021 09-30-2021 10-Q
12 10-12-2021 06-30-2021 10-K
13 05-14-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-Q
15 11-16-2020 09-30-2020 10-Q
16 10-13-2020 06-30-2020 10-K
17 06-22-2020 03-31-2020 10-Q
18 02-14-2020 12-31-2019 10-Q
19 11-15-2019 09-30-2019 10-Q
20 08-23-2019 06-30-2019 10-K
21 05-15-2019 03-31-2019 10-Q
22 02-14-2019 12-31-2018 10-Q
23 11-14-2018 09-30-2018 10-Q
24 10-12-2018 06-30-2018 10-K
25 05-21-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-Q
27 11-14-2017 09-30-2017 10-Q
28 09-28-2017 06-30-2017 10-K
29 05-15-2017 03-31-2017 10-Q
30 02-14-2017 12-31-2016 10-Q
31 11-14-2016 09-30-2016 10-Q
32 09-16-2016 06-30-2016 10-K
33 05-10-2016 03-31-2016 10-Q
34 02-09-2016 12-31-2015 10-Q
35 11-09-2015 09-30-2015 10-Q
36 09-14-2015 06-30-2015 10-K
37 05-15-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-Q
39 11-14-2014 09-30-2014 10-Q
40 09-29-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session
Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
06/14/2024 16:31:56

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/12/2024 16:31:05

nanoviricides-nv-387-results-show-flat-blood-concentration-profile-for-prolonged-antiviral-effect-in-clinical-trials
NanoViricides' NV-387 Results Show Flat Bl...
06/11/2024 10:43:13

A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID,...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/10/2024 16:31:08

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
06/05/2024 20:31:22

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 20:31:10

nanoviricides-reports-on-the-highly-desirable-blood-concentration-profile-of-its-lead-clinical-stage-broad-spectrum-antiviral-agent-nv-387-upon-intravenous-administration-in-a-non-human-primate-animal-model
NanoViricides Reports On The Highly Desira...
06/04/2024 11:03:17

The Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus i...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/03/2024 20:31:11

nanoviricides-elaborates-on-its-development-of-a-first-in-class-broad-spectrum-antiviral-agent-that-could-revolutionize-treatment-of-viral-infections-including-rsv-covid-influenzas-and-other-viruses
NanoViricides Elaborates On Its Developmen...
05/29/2024 10:38:55

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/16/2024 16:31:11

nanoviricides-reports-breakthrough-in-treating-airborne-viruses-boosting-lifespan-in-infected-mice
NanoViricides Reports Breakthrough in Trea...
05/08/2024 10:37:41

 NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that ...

ef-hutton-reiterates-buy-on-nanoviricides-maintains-65-price-target
EF Hutton Reiterates Buy on Nanoviricides,...
05/07/2024 13:51:38

EF Hutton analyst Tim Moore reiterates Nanoviricides (AMEX:NNVC) with a Buy and maintains $6.5 price target.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/06/2024 16:31:16

nanoviricides-broad-spectrum-antiviral-nv-387-offers-protection-against-influenza-a-and-bird-flu
NanoViricides' Broad-Spectrum Antiviral NV...
05/06/2024 10:33:56

NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that t...

nanoviricides-reports-that-the-phase-i-nv-387-clinical-trial-is-completed-successfully-and-data-lock-is-expected-soon
NanoViricides Reports That The Phase I NV-...
04/30/2024 10:34:02

ef-hutton-reiterates-buy-on-nanoviricides-maintains-65-price-target
EF Hutton Reiterates Buy on Nanoviricides,...
02/16/2024 12:14:32

EF Hutton analyst Tim Moore reiterates Nanoviricides (AMEX:NNVC) with a Buy and maintains $6.5 price target.

nanoviricides-q2-eps-018-down-from-015-yoy-as-of-december-31-2023-we-had-cash-and-cash-equivalent-current-assets-balance-of-approximately-531m-additional-agreements-have-resulted-in-a-further-approximately-25m-available-cash
Nanoviricides Q2 EPS $(0.18) Down From $(0...
02/15/2024 11:44:36

Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.18) per share. This is a 20 percent decrease over losses of $(0.15) ...

nanoviricides-explains-that-the-demonstration-of-strong-safety-and-tolerability-of-nv-cov-2-oral-drug-products-has-implications-beyond-covid
NanoViricides Explains That The Demonstrat...
02/01/2024 11:26:46

nanoviricides-says-the-healthy-subjects-part-of-the-phase-1a1b-clinical-trial-of-nv-cov-2-was-completed-successfully-and-no-adverse-events-were-reported-in-any-of-the-ascending-dose-cohorts
NanoViricides Says The Healthy Subjects Pa...
01/29/2024 11:33:30

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)